Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
10,245,689
-
Share change
-
-1,074,242
-
Total reported value
-
$29,916,489
-
Put/Call ratio
-
175%
-
Price per share
-
$2.92
-
Number of holders
-
46
-
Value change
-
-$2,471,402
-
Number of buys
-
20
-
Number of sells
-
24
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2022
As of 30 Sep 2022 Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,245,689 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, FMR LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Fosun International Ltd, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Steel Peak Wealth Management LLC, and KORNITZER CAPITAL MANAGEMENT INC /KS.
This table shows 46 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.